| 臺大學術典藏 |
2021-06-10T07:48:44Z |
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan
|
Yang, Yung-Li; Jaing, Tang-Her; Chen, Shih-Hsiang; Liu, Hsi-Che; Hung, Iou-Jih; Lin, Dong-Tsamn; Yang, Chao-Ping; Peng, Ching-Tien; Lin, Kai-Hsin; Hsiao, Chih-Cheng; Jou, Shiann-Tarng; Chen, Jiann-Shiuh; Lin, Ming-Tsan; Wang, Shih-Chung; Chang, Te-Kau; Huang, Fang-Liang; Cheng, Chao-Neng; Wu, Kang-Hsi; Sheen, Jiunn-Ming; Chen, Shu-Huey; MENG-YAO LU; Hung, Giun-Yi; Yen, Hsiu-Ju; Hsieh, Yuh-Lin; Wang, Jinn-Li; Chang, Yu-Hsiang; Chang, Hsiu-Hao; Yeh, Ting-Chi; Weng, Te-Fu; Hou, Jen-Yin; Chen, Bow-Wen; Chen, Rong-Long; Wang, Lin-Yen; Ho, Wan-Ling; Chen, Yu-Chieh; Cheng, Shin-Nan; Chao, Yu-Hua; Yang, Shang-Hsien; Huang, Ting-Huan; Chou, Shu-Wei; Lin, Chien-Yu; Chen, Hsuan-Yu; Chao, Yu-Mei Y; Liang, Der-Cherng; Chang, Tai-Tsung |
| 臺大學術典藏 |
2022-03-10T08:20:40Z |
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan
|
YUNG-LI YANG; Jaing, Tang-Her; Chen, Shih-Hsiang; Liu, Hsi-Che; Hung, Iou-Jih; Lin, Dong-Tsamn; Yang, Chao-Ping; Peng, Ching-Tien; Lin, Kai-Hsin; Hsiao, Chih-Cheng; Jou, Shiann-Tarng; Chen, Jiann-Shiuh; Lin, Ming-Tsan; Wang, Shih-Chung; Chang, Te-Kau; Huang, Fang-Liang; Cheng, Chao-Neng; Wu, Kang-Hsi; Sheen, Jiunn-Ming; Chen, Shu-Huey; Lu, Meng-Yao; Hung, Giun-Yi; Yen, Hsiu-Ju; Hsieh, Yuh-Lin; Wang, Jinn-Li; Chang, Yu-Hsiang; Chang, Hsiu-Hao; Yeh, Ting-Chi; Weng, Te-Fu; Hou, Jen-Yin; Chen, Bow-Wen; Chen, Rong-Long; Wang, Lin-Yen; Ho, Wan-Ling; Chen, Yu-Chieh; Cheng, Shin-Nan; Chao, Yu-Hua; Yang, Shang-Hsien; Huang, Ting-Huan; Chou, Shu-Wei; Lin, Chien-Yu; Chen, Hsuan-Yu; Chao, Yu-Mei Y; Liang, Der-Cherng; Chang, Tai-Tsung |
| 臺大學術典藏 |
2022-03-14T06:08:27Z |
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan
|
Yang Y.-L.; Jaing T.-H.; Chen S.-H.; Liu H.-C.; Hung I.-J.; Lin D.-T.; Yang C.-P.; Peng C.-T.; Lin K.-H.; Hsiao C.-C.; SHIANN-TANG JOU; Chen J.-S.; Lin M.-T.; Wang S.-C.; Chang T.-K.; Huang F.-L.; Cheng C.-N.; Wu K.-H.; Sheen J.-M.; Chen S.-H.; Lu M.-Y.; Hung G.-Y.; Yen H.-J.; Hsieh Y.-L.; Wang J.-L.; Chang Y.-H.; Chang H.-H.; Yeh T.-C.; Weng T.-F.; Hou J.-Y.; Chen B.-W.; Chen R.-L.; Wang L.-Y.; Ho W.-L.; Chen Y.-C.; Cheng S.-N.; Chao Y.-H.; Yang S.-H.; Huang T.-H.; Chou S.-W.; Lin C.-Y.; Chen H.-Y.; Chao Y.-M.Y.; Liang D.-C.; Chang T.-T. |
| 臺大學術典藏 |
2016 |
Treatment outcomes of supraglottoplasty for pediatric obstructive sleep apnea: A meta-analysis
|
Lee, Chia-Fan;Hsu, Wei-Chung;Lee, Chia-Hsuan;Lin, Ming-Tzer;Kang, Kun-Tai; Lee, Chia-Fan; Hsu, Wei-Chung; Lee, Chia-Hsuan; Lin, Ming-Tzer; Kang, Kun-Tai; WEI-CHUNG HSU |
| 臺大學術典藏 |
2018-09-10T18:05:39Z |
Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
|
Liang, J.-T. and Chen, T.-C. and Huang, J. and Jeng, Y.-M. and Cheng, J.C.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2019-11-18T08:17:49Z |
Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
|
YUNG-MING JENG;Liang, Jin-Tung;Cheng, Jason Chia-Hsien;Huang, John;Chen, Tzu-Chun; Liang, Jin-Tung; Chen, Tzu-Chun; Huang, John; YUNG-MING JENG; Cheng, Jason Chia-Hsien |
| 臺大學術典藏 |
2020-03-06T08:24:53Z |
Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
|
Liang J.-T.;Chen T.-C.;Huang J.;Yung-Ming Jeng;Cheng J.C.-H.; Liang J.-T.; Chen T.-C.; Huang J.; YUNG-MING JENG; Cheng J.C.-H. |
| 臺大學術典藏 |
2017 |
Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
|
CHIA-HSIEN CHENG; Jeng Y.-M.; Huang J.; Chen T.-C.; Liang J.-T.; Liang J.-T.;Chen T.-C.;Huang J.;Jeng Y.-M.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2021-05-03T02:20:52Z |
Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
|
JIN-TUNG LIANG; Chen T.-C.; Huang J.; Jeng Y.-M.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-02T14:00:05Z |
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
|
Liu, Yanfang; Tang, Chao Hsiun; Qiu, Hong; Siggins, Sarah; HSIN-AN HOU |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
|
Liu Y.; Tang C.-H.; Qiu H.; Siggins S.; HSIN-AN HOU |
| 國家衛生研究院 |
2022-12-15 |
Treatment patterns and healthcare utilization of patients with treatment-resistant depression estimated using health insurance database: A population-based study from Taiwan
|
Huang, WL;Chiang, CL;Wu, CS;Liao, SC;Chien, TH;Tseng, CH;Tang, CH |
| 國立成功大學 |
2020-10-14 |
Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan
|
Lin;Yih-Jyh;Lin;Chia-Ni;Sedghi;Tannaz;Hsu;Sylvia, H.;Gross;Cary, P.;Wang;Jung-Der;Wang;Shi-Yi |
| 臺北醫學大學 |
2012 |
Treatment Patterns of Breast Cancer Patients in Georgia Medicaid: Are Patterns Different for BCCPTA Women?
|
EK, Adams;LN, Chien;Gabram-M, S |
| 臺大學術典藏 |
2019-11-21T12:25:34Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Shen, Li Jiuan; Hsiao, Fei Yuan; Zhao, Zhongyun; Qian, Yi; Fox, Kathleen M.; Wen, Yao Chun; Lin, Lian Yu; Lin, Lian Yu;Wen, Yao Chun;Hsiao, Fei Yuan;Shen, Li Jiuan;Chen, Wen Jone;Fox, Kathleen M.;Qian, Yi;Zhao, Zhongyun;Rane, Pratik P.; Chen, Wen Jone; Rane, Pratik P. |
| 臺大學術典藏 |
2020-02-27T07:42:33Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.;Rane P.P.;Zhao Z.;Qian Y.;Lin L.-Y.;Shen L.-J.;Fox K.M.;Wen Y.-C.;WEN-JONE CHEN; WEN-JONE CHEN; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-04T07:44:28Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y.; Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; LIAN-YU LIN |
| 臺大學術典藏 |
2020-12-21T08:16:10Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.; Rane P.P.; Zhao Z.; Qian Y.; Lin L.-Y.; Shen L.-J.; Fox K.M.; Wen Y.-C.; WEN-JONE CHEN |
| 臺大學術典藏 |
2020 |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2020-12-24T03:00:35Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Hsiao F.-Y.; Rane P.P.; Zhao Z.; Qian Y.; Chen W.-J.; Wen Y.-C.; Fox K.M.; LI-JIUAN SHEN; Lin L.-Y. |
| 臺大學術典藏 |
2022-09-06T02:41:47Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; LIAN-YU LIN; Qian Y.; Zhao Z.; Rane P.P.; Hsiao F.-Y. |
| 臺大學術典藏 |
2022-09-19T03:16:39Z |
Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
|
Chen W.-J.; Wen Y.-C.; Fox K.M.; Shen L.-J.; Lin L.-Y.; Qian Y.; Zhao Z.; Rane P.P.; FEI-YUAN HSIAO |
| 臺北醫學大學 |
2014 |
Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: Non-isocentric CyberKnife versus isocentric RapidArc
|
Lin, Yu-Wei;Lin, Kuei-Hua;Ho, Hsiu-Wen;Lin, Hsiu-Man;Lin, Li-Ching;Lee, Steve P.;Chui, Chen-Shou |
| 國立高雄師範大學 |
2002 |
Treatment program planning by speech therapists in Taiwan
|
曾進興; Chin-Hsing Tseng;W. Y. Chang |
| 國立臺灣大學 |
2008 |
Treatment Recommendations of Hospital-Acquired Pneumonia in Asian Countries: First Consensus Report by the Asian Hap Working Group
|
薛博仁; HSUEH, PO-REN |
| 國立成功大學 |
2012-01 |
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
|
Chang, Hui Hua; Lee, I. Hui; Gean, Po Wu; Lee, Sheng-Yu; Chi, Mei Hung; Yang, Yen Kuang; Lu, Ru-Band; Chen, Po See |
| 高雄醫學大學 |
2010 |
Treatment response in Asian HCV: Different to the West
|
余明隆 |
| 臺大學術典藏 |
2020-10-22T07:27:42Z |
Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab
|
TSEN-FANG TSAI; Chiu T.-S. |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
|
Chiang C.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2021-01-06T08:23:27Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.;Yao-Hsu Yang;Chiang B.-L.; Su Y.; YAO-HSU YANG; Chiang B.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:22Z |
Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
|
Su Y.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2018-09-10T18:06:52Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai, M.-S. and Chang, S.-Y. and Lin, S.-W. and Kuo, C.-H. and Sun, H.-Y. and Wu, B.-R. and Tang, S.-Y. and Liu, W.-C. and Su, Y.-C. and Hung, C.-C. and Chang, S.-C.; CHING-HUA KUO; SHAN-CHWEN CHANG; HSIN-YUN SUN |
| 臺大學術典藏 |
2020-03-09T06:08:10Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Shu-Wen Lin;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Sui-Yuan Chang;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; SUI-YUAN CHANG; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2017 |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; HSIN-YUN SUN; Kuo C.-H.; Lin S.-W.; Chang S.-Y.; Tsai M.-S.; Chang S.-C.; Hung C.-C.; Liu W.-C.; Su Y.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:13Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Chang S.-Y.;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Shan-Chwen Chang; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-04T06:23:11Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 高雄醫學大學 |
2008 |
Treatment results for children with acute myeloid leukemia inTaiwan
|
梁德成;張泰琮;TPOG團隊 |
| 國立臺灣大學 |
1999 |
Treatment Results of Carcinoma of the Nasal Cavity
|
許智捷; 鍾娜娜; 雷德; 丁禮莉; HSU, CHIH-CHIECH; CHUNG, NA-NA; LUI, LOUIS TAK; TING, LAI-LEI |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 中國醫藥大學 |
2007-07 |
Treatment Results of Hypopharyngeal Cancer Based on Definitive Radiotherapy
|
陳邦瑜(Pang-Yu Chen); 楊世能(Shih-Neng Yang); 梁基安(Ji-An Liang); 蔡銘修(Ming-Hsui Tsai); 陳尚文(Shang-Wen Chen)*; 林芳仁 |
| 國立臺灣大學 |
2000 |
Treatment Results of the Tpog-Nhl92 Protocols for Childhood Non-Hodgkin's Lymphomas in Taiwan: A Report from the Taiwan Pediatric Oncology Group ( Tpog)
|
盧孟佑; LU, MENG-YAO |
| 臺大學術典藏 |
2018-09-10T03:32:24Z |
Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: A report from the Taiwan Pediatric Oncology Group (TPOG)
|
Yang, C.-P.;Hung, I.-J.;Jaing, T.-H.;Lin, K.-H.;Lin, D.-T.;Lu, M.-Y.;Liang, D.-C.;Chen, S.-H.;Liu, H.-C.;Hsiao, C.-C.;Shu, S.-G.;Chen, J.-S.;Chang, T.-T.;Chiou, S.-S.;Hsieh, Y.-L.;Lin, M.-T.;Lee, M.-T.;Peng, C.-T.;Cheng, S.-N.;Chen, R.-L.;Chen, B.-W.;Lin, K.-S.; KAI-HSIN LIN |
| 臺大學術典藏 |
2020-12-16T07:22:10Z |
Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: A report from the Taiwan Pediatric Oncology Group (TPOG)
|
Chen J.-S.; Chang T.-T.; Chiou S.-S.; Hsieh Y.-L.; Lin M.-T.; Lee M.-T.; Peng C.-T.; Cheng S.-N.; Chen R.-L.; Chen B.-W.; Lin K.-S.; Yang C.-P.;Hung I.-J.;Jaing T.-H.;Lin K.-H.;Lin D.-T.;Meng-Yao Lu;Liang D.-C.;Chen S.-H.;Liu H.-C.;Hsiao C.-C.;Shu S.-G.;Chen J.-S.;Chang T.-T.;Chiou S.-S.;Hsieh Y.-L.;Lin M.-T.;Lee M.-T.;Peng C.-T.;Cheng S.-N.;Chen R.-L.;Chen B.-W.;Lin K.-S.; Yang C.-P.; Hung I.-J.; Jaing T.-H.; Lin K.-H.; Lin D.-T.; MENG-YAO LU; Liang D.-C.; Chen S.-H.; Liu H.-C.; Hsiao C.-C.; Shu S.-G. |
| 國立成功大學 |
2023 |
Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Discontinuation: A Population-based Cohort Study
|
Lin, C.-H.;Lin, H.-L.;Chiang, Chiang C.-L.;Chen, Y.-W.;Liu, Y.-F.;Yang, Yang Y.-K.;Tang, C.-H. |
| 臺大學術典藏 |
2021-09-13T05:41:53Z |
Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
|
Kaufmann C.N.; LIAN-YU CHEN; Crum R.M.; Mojtabai R. |
| 臺大學術典藏 |
2018-09-10T05:12:48Z |
Treatment strategies for developing class III patients
|
Chang, F.H.F.;Chang, J.Z.C.; JENNY ZWEI-CHIENG CHANG |
| 臺大學術典藏 |
2021-07-07T01:20:32Z |
Treatment strategies for developing class III patients
|
Chang F.H.F.; JENNY ZWEI-CHIENG CHANG |
